跳至主要内容
临床试验/NCT00313573
NCT00313573Unknown3 期

TeleCare Management of Pain and Depression in Cancer

Indiana University Melvin and Bren Simon Cancer Center34 个研究点 分布在 1 个国家目标入组 480 人开始时间: 2006年2月最近更新:
适应症

试验速览

阶段
3 期
发起方
入组人数
480
试验地点
34
主要终点
Compare efficacy of 3-component model telemedicine intervention to standard care in terms of depression and pain at baseline and 1, 3, 6, and 12 months

研究概览

简要总结

RATIONALE: Telemedicine may help in the treatment of depression and/or pain caused by cancer. It is not yet known whether telemedicine is more effective than standard care in treating depression and/or pain caused by cancer.

PURPOSE: This phase III randomized clinical trial is studying telemedicine to see how well it works compared to standard care in treating patients with depression and/or pain caused by cancer.

详细描述

OBJECTIVES:

Primary

  • Compare the effectiveness of a state-wide, telemedicine intervention with standard care in cancer patients with clinical depression and/or cancer-related pain.
  • Compare improvement in clinical depression and/or cancer-related pain in patients undergoing these interventions.

Secondary

  • Compare health-related quality of life, functional status, and patient satisfaction with treatment in patients undergoing these interventions.
  • Compare the economic benefits of these interventions in these patients.

研究设计

研究类型
Interventional
分配方式
Randomized

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Compare efficacy of 3-component model telemedicine intervention to standard care in terms of depression and pain at baseline and 1, 3, 6, and 12 months

次要结局

  • Health-related quality of life at baseline and 1, 3, 6, and 12 months
  • Cost-effectiveness of care at baseline and 1, 3, 6, and 12 months
  • Treatment satisfaction at baseline and 1, 3, 6, and 12 months

研究者

发起方
Indiana University Melvin and Bren Simon Cancer Center
申办方类型
Other

研究点 (34)

Loading locations...

相似试验

Telemedicine or Standard Care in Treating Patients... | 临床试验